HealthZA
South Africa's Twice-Yearly HIV Shot Has a Delivery Problem, Not a Science Problem
Lenacapavir could reshape HIV prevention in South Africa, but the June rollout shows the hard part is access, staffing, funding, and trust.
Lenacapavir could reshape HIV prevention in South Africa, but the June rollout shows the hard part is access, staffing, funding, and trust.